Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers.
about
Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytesProteomic profiling of Myc-associated proteinsSRBC/cavin-3 is a caveolin adapter protein that regulates caveolae functionMSRE-PCR for analysis of gene-specific DNA methylationDNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateCavin-3 dictates the balance between ERK and Akt signaling.Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains.Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancerCaveolae, caveolins, and cavins: complex control of cellular signalling and inflammation.Identification of epigenetically regulated genes that predict patient outcome in neuroblastomaClinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.Chromosomal aberrations related to metastasis of human solid tumorsMURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes.A seven-gene CpG-island methylation panel predicts breast cancer progressionNaturally occurring variation in trophoblast invasion as a source of novel (epigenetic) biomarkersPolymorphisms in PRKCDBP, a Transcriptional Target of TNF-α, Are Associated With Inflammatory Bowel Disease in Korean.DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polypsParallel assessment of CpG methylation by two-color hybridization with oligonucleotide arraysEpigenetic targeting in breast cancer: therapeutic impact and future direction.Epigenomics and breast cancerAberrant promoter CpG methylation and its translational applications in breast cancer.Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer.Nanochelating based nanocomplex, GFc7, improves quality and quantity of human mesenchymal stem cells during in vitro expansion.Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth.Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis.A Role for the Cavin-3/Matrix Metalloproteinase-9 Signaling Axis in the Regulation of PMA-Activated Human HT1080 Fibrosarcoma Cell Neoplastic Phenotype.A new regulator of caveolae signalling.Identification and characterization of renal cell carcinoma gene markers.PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling.
P2860
Q24298730-30E421C5-12BA-497B-BFDA-E7BA6F564A14Q24315890-9F2D035B-99CA-4DBE-8E40-1B6444BBF2B0Q24317453-240D7ADC-D6FA-475B-AA17-863F65BBDE03Q24810367-25DCC73E-1BD5-4E94-8D57-6E9B65E73EA3Q28386334-ED248691-080B-44DA-BD0C-2C82064437FAQ29347262-173AC654-E7C7-4D1E-AD44-35D2944E0CE5Q33230939-01967F10-9F4B-438C-BDB4-D09911A893E9Q33239655-A34DD4FF-7DED-4C09-A26A-49482F5BD666Q33471495-A4C6D1DC-5D22-4532-90B6-3EB1577BC455Q33795736-CF8BA2C7-E30B-4E16-BD3C-AA531B4ABC3CQ33818726-746AB287-063B-40BE-9F46-B24355EA5A1CQ34464472-EBA78139-BA33-4D84-817E-0E53D699FE69Q34961715-35735624-DD1A-4BF4-920D-18DB50E3BE5BQ34988286-53BDEB07-9EC2-4A95-8751-9884C5B90A8AQ35626799-FE502BAE-8262-44D0-BECE-C164D4F74F67Q35764931-A6DEA74A-C7D4-4D07-BDF2-F2280281BE85Q35777877-6546792E-38D8-44E5-8535-19AAC3059F49Q35785652-49B17715-AD11-45F6-9E33-8BC869924196Q36359174-60700F57-6027-4DAA-BAE8-86B54378A5E6Q36856318-876ACD1C-1186-4694-B805-C4D941B75EC7Q37078784-DC87486E-BA7E-4287-BB1D-95035683E563Q37354053-D9A6C37F-4D22-4A19-ABF3-A79263975465Q37532630-D7DACB31-6F0A-4841-A795-669BEB0D3F71Q38939663-CEB95064-1071-402F-8C8F-1BA5458BF44AQ40409439-2B13C716-C519-4A2E-B496-4F0A2936EA64Q41916780-0CEFB20E-1EAC-4930-8D60-A59E2234734FQ42470449-3388D429-1F9E-483F-8EBE-598070985FA1Q42971441-48AA41D2-F1B1-44B9-BDEB-578BF332D7BAQ43137048-90DF85E1-EF26-4501-AE0D-7732F418E0CFQ55012187-8B3FFBF8-0366-456C-8D24-F76EA7199929
P2860
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Inactivation of human SRBC, lo ...... n, in breast and lung cancers.
@en
Inactivation of human SRBC, lo ...... n, in breast and lung cancers.
@nl
type
label
Inactivation of human SRBC, lo ...... n, in breast and lung cancers.
@en
Inactivation of human SRBC, lo ...... n, in breast and lung cancers.
@nl
prefLabel
Inactivation of human SRBC, lo ...... n, in breast and lung cancers.
@en
Inactivation of human SRBC, lo ...... n, in breast and lung cancers.
@nl
P2093
P1433
P1476
Inactivation of human SRBC, lo ...... on, in breast and lung cancers
@en
P2093
Bowcock AM
Tomizawa Y
Tomlinson G
P304
P407
P577
2001-11-01T00:00:00Z